Definition and expression in E. coli of large fragments from the human lipid kinase phosphatidylinositol 4-kinase type III alpha, and purification of a 1100-residue N-terminal module

详细信息    查看全文

• 作者：Cyntia Taveneau ; Karine Blondeau ; Sté ; phane Bressanelli ; ^{stephane.bressanelli@i2bc.paris-saclay.fr" class="auth_mail" title="E-mail the corresponding author}
• 关键词：PI4KIII ; phosphatidylinositol-4-kinase of type III ; PI4KA ; (human) phosphatidylinositol-4-kinase III伪 ; PI4P ; phosphatidylinositol-4 phosphate ; PI3K ; phosphatidylinositol-3-kinase ; HCV ; hepatitis C virus ; SEC ; size exclusion chromatography
• 刊名：Protein Expression and Purification
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：114
• 期：Complete
• 页码：121-127
• 全文大小：1521 K

文摘

The eukaryotic lipid kinase phosphatidylinositol 4-kinase III alpha (PI4KA in higher eukaryotes) is a ubiquitous enzyme that synthesizes the plasma membrane pool of phosphatidylinositol 4-phosphate. This important phosphoinositide has key roles in different signalization pathways, vesicular traffic and cellular compartment identity. Moreover, human PI4K4A is an essential factor for hepatitis C virus replication. PI4KA is a large protein (2102 residues for human PI4KA) with the kinase domain making up the ca 400 C-terminal residues. There is essentially no structural information about the 1500 N-terminal residues and no clue as to the function of most of this region of PI4KA.

In this report, we use computational methods in order to delineate fragments of human PI4KA amenable to soluble production in Escherichia coli. We clone and express these fragments as GST-fusions and evaluate the soluble fraction of each protein. Finally, we produce and purify to homogeneity a 1100-residue PI4KA N-terminal fragment. Our results further suggest that PI4KA can be described as a two-module protein. They open the way to structural characterization of the N-terminal regulatory module of PI4KA.